Latest natalizumab PML risk update

L
The latest PML risk figures from Biogen. If you are on natalizumab and are JCV seropositive this post is for you.


ProfG    









About the author

Gavin

Professor of Neurology, Barts & The London. MS & Preventive Neurology thinker, blogger, runner, vegetable gardener, husband, father, cook and wine & food lover.

3 comments

  • Please do you have any comments on the data about 27% free of disease activity at 24 months? I thought it is more as natalizumab is one of the most potent medicines …

By Gavin

Translate

Categories

Recent Posts

Recent Comments

Archives